Delivery Order SPE2DB25D3020-SPE2DB25FWHHY

Award Date 5/6/25
Potential Completion Date 5/7/25
Potential Value $4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,540.60 Firm Fixed Price Delivery Order contract is for the supply of XTAMPZA ER 13.5 MG CAPSULE 100S, a pharmaceutical product. The contract has an ultimate completion date of February 26, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $4,439.20, is for the delivery of XTAMPZA ER 18 MG CAPSULE 100S, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of January 22, 2025. This award is not associated with a set-aside designation. AmerisourceBergen Drug...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,587.84 firm-fixed-price delivery order is for the supply of XTAMPZA ER 9 MG CAPSULE 100S, a specialty pharmaceutical product. The contract has an ultimate completion date of October 30, 2024 and was awarded on October 29, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) between...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,863.30 firm fixed-price delivery order is for the supply of XTAMPZA ER 36 MG capsules. The contract has an ultimate completion date of February 12, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,544.57, is for the delivery of XTAMPZA ER 9 MG CAPSULE 100S, a prescription medication. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of January 22, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,787.26, is for the delivery of XTAMPZA ER CAPS 36MG, a pharmaceutical product. The contract has a completion date of November 21, 2024 and is a Firm Fixed Price Delivery Order. The contract is not designated as a set-aside. AmerisourceBergen holds a larger Indefinite Delivery...
This is a federal delivery order contract awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency. The $1,122.80 firm-fixed-price contract is for the supply of XTAMPZA ER CAPS 13.5MG, a prescription pharmaceutical product. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
This is a $6,059.05 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the supply of XTAMPZA ER CAPS 18MG, a prescription medication. The order has a completion date of July 18, 2024. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued up to $999,999,999 and $750,000 respectively, to...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,454.28, is for the delivery of XTAMPZA ER CAPS 36MG, a specialty medication. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which serves as a primary vehicle for providing...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,379.48, is a Delivery Order awarded under the DLA's Indefinite Delivery Contract (IDC) for providing XTAMPZA ER 9 MG CAPSULE 100S, a specialty pharmaceutical product. Amerisourcebergen holds a $999,999,999 IDC with DLA Troop Support Medical to supply a wide range of...
  • SPE2DB25D3020
    Indefinite Delivery Contract
  • SPE2DB25D3020-SPE2DB25FWHHY
    Delivery Order

This federal contract award, with a ceiling value of $4,028.92, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of XTAMPZA ER 36 MG CAPSULE 100S, a prescription medication. The contract type is a Delivery Order with a Firm Fixed Price pricing structure, and the ultimate completion date is May 7, 2025.

Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. This IDC enables the company to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard. The contract award described in the provided information is not designated as a set-aside.

Generated 8/10/25, 1:02 AM